Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04358458
Title First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | ESP | DNK | BEL

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 United States Details
The University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98133 United States Details
UZ Leuven Leuven Belgium Details
Rigshospitalet Copenhagen Denmark Details
Odense Universitetshospital Odense Denmark Details
Vejle Sygehus Vejle Denmark Details
Amsterdam UMC, Locatie VUMC Amsterdam Netherlands Details
ICO Badalona - Hospital Universitari Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
ICO l'Hospitalet - Hospital Duran i Reynals Barcelona L'Hospitalet De Llobregat 08908 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clinic de Barcelona Barcelona Spain Details
Hospital Universitario Fundacion Jimenez Diaz Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field